SGHT
HealthcareSight Sciences Inc
Live · NASDAQ · May 9, Close
What's Moving SGHT Today?
No stock-specific AI insight has been generated for SGHT yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
SGHT News
21 articles- Sight Sciences Financial Results for Q1 2026 Show GrowthVisionMonday.com·May 8, 2026
- Sight Sciences Q1 Earnings Call HighlightsMarketbeat·May 7, 2026
- Sight Sciences, Inc. Q1 2026 Earnings Call SummaryMoby·May 7, 2026
- Sight Sciences (SGHT) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesYahoo Finance·May 6, 2026
- Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 6, 2026
- Sight Sciences (SGHT) Q1 2026 Earnings TranscriptMotley Fool·May 6, 2026
- Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue GuidanceYahoo Finance·May 6, 2026
- Sight Sciences to Present at Two Upcoming Investor ConferencesYahoo Finance·Apr 29, 2026
- Fuel Tech Leads The Pack Of 3 Noteworthy Penny StocksYahoo Finance·Apr 29, 2026
- Sight Sciences Announces the Release of its Sustainability ReportYahoo Finance·Apr 22, 2026
- Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026Yahoo Finance·Apr 21, 2026
- Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual MeetingYahoo Finance·Apr 1, 2026
- Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13thYahoo Finance·Mar 30, 2026
- Arq And 2 Other Promising Penny StocksYahoo Finance·Mar 30, 2026
- Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury’s Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® MicrostentYahoo Finance·Mar 30, 2026
- Sight Sciences, Inc. Q4 2025 Earnings Call SummaryMoby·Mar 5, 2026
- Sight Sciences Inc (SGHT) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ...Yahoo Finance·Mar 5, 2026
- Sight Sciences Q4 Earnings Call HighlightsMarketbeat·Mar 5, 2026
- Sight Sciences (SGHT) Q4 2025 Earnings TranscriptMotley Fool·Mar 4, 2026
- Sight Sciences (SGHT) Reports Q4 Earnings: What Key Metrics Have to SayYahoo Finance·Mar 4, 2026
- Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue EstimatesYahoo Finance·Mar 4, 2026
All 21 articles loaded
Price Data
Fundamentals
Trading
About Sight Sciences Inc
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.